Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-06-24 16:04:28 ET · period of report 2026-06-22 · accession 0000905148-26-003076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-24 16:04 | 2026-06-22 | RIGL | Ali-Jackson Kamil | Dir | S - Sale | $35.00 | -2,500 | 10.1K | -20% | -$87.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | S | D | 2,500 | $35.00 | 10,125 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. (F2) The shares sold in this transaction were sold to cover applicable tax withholding obligations incurred upon the vesting of restricted stock units and were not sold for investment purposes. |